A transcriptional and cellular exploration of obesity and type II diabetes in human adipose tissues
Science Advances · 06.11.2026 · 12 (45)
DOI: 10.1126/sciadv.aee1641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.11.2026. Verfasst von William V Trim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Obesity, Adipose Tissue. Die Arbeit nennt 145 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, Ludwig Institute for Cancer Research.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Obesity is tightly linked to metabolic disorders such as type II diabetes mellitus (T2D), although a subpopulation of individuals with obesity do not present with these morbidities. The biological factors conferring T2D vulnerability remain incompletely understood. We recruited 58 individuals with obesity with or without a clinical diagnosis of T2D (Ob + T2D and Ob). We profiled paired samples of omental and subcutaneous adipose by single-cell RNA sequencing ( n = 10), flow cytometry under basal and stimulated conditions ( n = 42), and histology ( n = 17). Flow cytometry and chemokine quantification were also performed in paired whole blood. We identified reprogramming of the omental stromal compartment, centered on mesothelial and endothelial cells, alongside contrasting innate T cell and macrophage phenotypes across depots. Mesothelial and IGFBP2 + cells exhibited a fibrotic, epithelial-mesenchymal transition–like phenotype, while omental endothelial cells exhibited a lipid-overload, inflammatory, antigen presentation profile in T2D. Omental and subcutaneous adipose innate T cells exhibited divergent inflammatory profiles between tissues. These findings reveal previously unidentified insights into the pathophysiology of T2D in adipose tissue and identify compensatory networks within the tissues that could be exploited by targeted therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
- Department of Systems Biology, Harvard Medical School, Boston, MA, USA.
- Ludwig Institute for Cancer Research, Princeton Branch, Princeton, NJ, USA.
- Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
- Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
ORCID-Profile: William V Trim, Kseniia Petrova, John G Scanlan, Katie L O'Brien, Lydia Lynch
Förderung
- NIAID NIH HHS
- National Institutes of Health
- Ludwig Institute for Cancer Research
- Science Foundation Ireland
- Vetenskapsrådet
Zitieren
APA
Trim, W. V., Petrova, K., Healy, K., Stevens, B. M., Scanlan, J. G., Faust, H. J., Svensson Akusjärvi, S., O'Brien, K. L., O'Shea, D., Brenner, M. B., Heneghan, H., & Lynch, L. (2026). A transcriptional and cellular exploration of obesity and type II diabetes in human adipose tissues. Science Advances, 12(45). https://doi.org/10.1126/sciadv.aee1641
Vancouver
Trim WV, Petrova K, Healy K, Stevens BM, Scanlan JG, Faust HJ, et al. A transcriptional and cellular exploration of obesity and type II diabetes in human adipose tissues. Science Advances. 2026;12(45). doi:10.1126/sciadv.aee1641
BibTeX
@article{Trim2026,
author = {Trim, William V and Petrova, Kseniia and Healy, Katie and Stevens, Brenneth M and Scanlan, John G and Faust, Heather J and Svensson Akusjärvi, Sara and O'Brien, Katie L and O'Shea, Donal and Brenner, Michael B and Heneghan, Helen and Lynch, Lydia},
title = {A transcriptional and cellular exploration of obesity and type II diabetes in human adipose tissues},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {45},
doi = {10.1126/sciadv.aee1641}
}
EUVIMED